Table:
begin	end	state
1	5	non-cytoplasmic
6	39	transmembrane
40	89	cytoplasmic
90	109	transmembrane
110	130	non-cytoplasmic
131	160	transmembrane
161	171	cytoplasmic
172	197	transmembrane
198	207	non-cytoplasmic
208	232	transmembrane
233	252	cytoplasmic
253	279	transmembrane
280	284	non-cytoplasmic
285	303	transmembrane
304	316	cytoplasmic
317	339	transmembrane
340	353	non-cytoplasmic
354	372	transmembrane
373	377	cytoplasmic
378	396	transmembrane
397	399	non-cytoplasmic
400	425	transmembrane
426	444	cytoplasmic
445	466	transmembrane
467	475	non-cytoplasmic

Input:
>WP_041937010.1 NCBI__GCF_000009265.1:WP_041937010.1
MTDAHIAVGMLLILILTIFLGFPVAFTLMALGVGFGYYAYFDAGRMWRGYDRALESGGDA
ATLAQTWIGGFFNNRIFDLFVNQTYSVIQNDVLTAIPLFLFMGYIVERANIVDRLFSTLF
NVTRRVPGSMAVAALVTCTLFATATGIVGAVVTLMGLLALPAMLKAKYDVRYATGVICAG
GTLGILIPPSILLIVYAATSGISVVRMYAAALLPGLALAGFYLIYVVVRAILQPQLAPRP
TKEDVGEHTPVQLAWMMLTSFAPLAFLILAVLGAILFGLATPSEAAAIGALGGLALAAAY
RALTWQRLKESVYLTARTTAMVCWLFVGSATFASVFAYLGGQQFISDFVTGLDMSPLMFL
ILAQIIIFILGWPLEWTEIIVIFIPIFIPLLPHFGIDPLFFGILVAINLQTAFLSPPMAM
SAYYLKGVSPPHVKLTDIFRGMMPYMLIVILCMVFIYLFPSIVYMLPNLLYGGQR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server